ArticleCurrent oncology (Toronto, Ont.)2022

Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's RWE Data Working Group.

Wei Fang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.